Scinai Immunotherapeutics Ltd. - American Depositary Shares SCNI 深 滬
已收盤 07-18 16:00:00 美东时间
2.15
+0.007
+0.31%
華盛通- 最 高2.15
- 今 開2.14
- 成交量 6.71万股
- 最 低 2.10
- 昨 收 2.1434
- 總市值 214.98万
- 52周最高 6.18
- 市盈率 靜 0.36
- 換手率 0.00%
- 52周最低 1.90
- 委 比 -37.11%
- 總股本 99.99万
- 歷史最高 6200.00
- 量 比 0.75
- 振 幅 2.33%
- 歷史最低 1.90
- 每 手 1
- 風險率 0.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Scinai Immunotherapeutics shares are trading higher after the company announced that it was granted clearance under the Golden Power regulation for Scinai's option to acquire 100% of the share capital and voting rights of Pincell.
Scinai Immunotherapeutics shares are trading higher after the company announced...
06-05 22:37
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q4 ea...
06-05 11:55
Scinai Immunotherapeutics Reports Strong CDMO Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q1 ea...
06-03 11:54
Scinai Immunotherapeutics reports FY results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): FY Revenue of $0.65M. Financial income, net in 2024, amounted to $13.5 million compared to $3.2 million for 2023. The increase was primarily due...
05-08 05:46
Scinai Announces Annual Financial Results for 2024
JERUSALEM, May 7, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative biol...
05-08 04:01
Scinai Immunotherapeutics to Acquire Pincell for Novel Skin Disorder Treatment
Scinai Immunotherapeutics ( ($SCNI) ) has issued an update. On March 27, 2025, ...
03-28 00:48
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
Scinai Immunotherapeutics (NASDAQ:SCNI) said on that it has entered into a standby equity purchase agreement with YA II PN, a fund managed by Yorkville Advisors Global. Under the terms of the SEPA, Sc...
03-05 20:49
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
JERUSALEM, March 5, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunol...
03-05 20:30
Scinai Immunotherapeutics Secures $10 Million Equity Purchase Agreement
Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On March 3, 2...
03-05 05:57
